Journal ArticleOPEN ACCESS

In Reply

  • Rosen A
  • Gavrilovic I
  • Balagula Y
  • et al.
The Oncologist (2013) 18(4) e18-e18
DOI: 10.1634/theoncologist.2012-0421
0Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This reply to the letter by Hubiche et al. further discusses the hypothesis that geographic tongue is a novel entity related to bevacizumab therapy.

Cite

CITATION STYLE

APA

Rosen, A. C., Gavrilovic, I. T., Balagula, Y., Ramaswamy, V., Dickler, M. N., Dunkel, I. J., & Lacouture, M. E. (2013). In Reply. The Oncologist, 18(4), e18–e18. https://doi.org/10.1634/theoncologist.2012-0421

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free